arterial thrombotic disease - HEALTHIES
Major arterial or venous thrombotic complications, major adverse cardiovascular events, and symptomatic venous thromboembolism (VTE) occur frequently in the first 30 days after admission to the ICU ... The New England Journal of Medicine: Endovascular Therapy for Post-Thrombotic Syndrome — A Randomized Trial Post-thrombotic syndrome is common after deep-vein thrombosis and can cause severe symptoms involving the limbs that impair patients’ activity and quality of life. Endovascular therapy can ...
Understanding the Context
Some patients with COVID-19 develop symptomatic arterial thrombosis in their legs that is difficult to eradicate by usual means and portends worse outcomes, new data show. The small study of COVID-19 ... The American Journal of Managed Care: Real-world Study Shows Ruxolitinib May Reduce Arterial Thrombosis in Polycythemia Vera Previous studies have shown ruxolitinib effective in symptom relief and hematocrit control for hydroxyurea-resistant polycythemia vera, but its role in disease progression is not yet clear. The most ...
Image Gallery
Key Insights
AHA/ASA Journals: Olfactory Receptor Activation Reduces Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton Remodeling Olfactory Receptor Activation Reduces Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton Remodeling